Mar 21, 2023 | Covid-19, News
Scanning electron micrograph of a cell (purple) infected with the Omicron strain of SARS-CoV-2 virus particles (orange), isolated from a patient sample and colorized. CREDIT: NIAID/NIH The magnitude and quality of a key immune cell’s response to vaccination with two... 
Mar 14, 2023 | Covid-19, News
An observational study of nearly 400,000 nonhospitalized adults in California finds a low rate of venous thromboembolism (VTE, or a blood clot in a vein) in the 30 days after COVID-19 diagnosis and an even lower rate in the following 30 days. In the University of... 
Feb 28, 2023 | Covid-19, News
One of the newly discovered class 6 antibodies (blue) attaching to the SARS-CoV-2 spike protein (green) in a way that causes the spike to break up. CREDIT: Garvan Institute of Medical Research A new class of SARS-CoV-2 antibodies has been shown to neutralize multiple... 
Feb 28, 2023 | Covid-19, News
The newly authorized Lucira at-home test for SARS-COV-2 and influenza A and B. CREDIT: Lucira Health The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test that can... 
Feb 28, 2023 | Covid-19, News
Protein-based nanoparticles bind to the SARS-CoV-2 spike protein, preventing infection. The developed nanospheres could have applications in biomedicine. CREDIT: Molood Behbahanipour, Roger Benoit, Susanna Navarro, Salvador Ventura Universitat Autònoma de Barcelona...
